UP1002
/ UPPTHERA
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 28, 2025
N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer.
(PubMed, Pharmaceutics)
- "In vivo, NC1 suppressed tumor growth in a HeLa xenograft mouse model. This research highlights the potential of N-degron-based PROTACs targeting the PLK1 protein in cancer therapies, highlighting their potential in future cervical anticancer treatment strategies."
Journal • Cervical Cancer • Oncology • Solid Tumor • Targeted Protein Degradation • PLK1
1 to 1
Of
1
Go to page
1